Company page

Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a public company traded under the ticker GENB on the American market. The company has a market capitalization of approximately $1.86 billion. Generate Biomedicines focuses on developing innovative biomedicine solutions.

profileGENB:NASDAQAI content: aiUpdated June 24, 2026/company/generate-biomedicines-inc-common-stock/c-5vxlowy9
Generate Biomedicines, Inc. logo
Ticker
GENB:NASDAQ
Asset type
Stock
Market cap
$1.86B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD